Acinetobacter calcoaceticus BY PCR

The Acinetobacter calcoaceticus BY PCR test is a molecular assay that detects the presence of Acinetobacter calcoaceticus DNA in clinical specimens using polymerase chain reaction (PCR). This method delivers sensitive and specific qualitative detection, allowing faster identification than conventional culture-based techniques and enabling prompt clinical decision-making.

This home-based lab service in Dubai is suitable for patients with suspected wound, respiratory, urinary, or bloodstream infections where Acinetobacter species are a concern, especially in healthcare-associated or post‑surgical contexts. Results support targeted antimicrobial therapy and infection‑control measures; however, findings should be interpreted by a clinician alongside culture and susceptibility data when available.

• Acinetobacter calcoaceticus DNA (qualitative detection)
• PCR result (Positive / Negative)
• Cycle threshold (Ct) value (when reported)
• Specimen type documented

• Suspected hospital‑acquired or surgical site infection
• Respiratory infection or ventilator‑associated pneumonia
• Non‑healing wound or persistent wound drainage
• Fever or sepsis of unknown origin with recent healthcare exposure
• Failure to respond to empirical antibiotic therapy

• Rapid, sensitive molecular detection compared with culture
• Enables earlier targeted antibiotic therapy
• Reduces unnecessary broad‑spectrum antibiotic use
• Home collection in Dubai by trained, licensed personnel
• Supports infection‑control and outbreak investigations

• Appropriate clinical specimen collected by a trained technician (wound swab, respiratory secretion, or other site‑specific swab)
• No fasting required prior to sample collection
• Inform the collector of current antibiotics, recent hospitalisation, or medical devices (e.g., ventilator, catheter)
• Patient or guardian available at scheduled home visit with Emirates ID for verification